Auswahl neuerer Veröffentlichungen:
Hannafon BN, Cai A, Calloway CL, Xu YF, Zhang R, Fung KM and Ding WQ (2019). miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study. BMC Cancer 19(1), 642
Giordano A, Liu Y, Armeson K, Park Y, Ridinger M, Erlander M, Reuben J, Britten C, Kappler C, Yeh E and Ethier S (2019). Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One 14(11), e0224420
Hale SJ, Jimenez-Pascual A, Kordowski A, Pugh J, Rao S, Silver DJ, Alban T, Watson DB, Chen R, McIntyre TM, Colombo G, Taraboletti G, Holmberg KO, Forsberg-Nilsson K, Lathia JD and Siebzehnrubl FA (2018). ADAMDEC1 maintains a novel growth factor signaling loop in cancer stem cells. doi: http://dx.doi.org/10.1101/5315...
Sun L et al. (2019). miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44. Theranostics 9(26), 8409-8425
Kessel D (2019). Pathways to Paraptosis After ER Photodamage in OVCAR-5 Cells. Photochem Photobiol. 2019 Mar 29. doi: 10.1111/php.13103. [Epub ahead of print]
Wienholz F, Zhou D, Turkyilmaz Y, Schwertman P, Tresini M, Pines A, van Toorn M, Bezstarosti K, Demmers JAA and Marteijn JA (2019). FACT subunit Spt16 controls UVSSA recruitment to lesion-stalled RNA Pol II and stimulates TC-NER. Nucleic Acids Res. 2019 Feb 4. doi: 10.1093/nar/gkz055. [Epub ahead of print]
Ha JR, Ahn R, Smith HW, Sabourin V, H?bert S, Cepeda Cañedo E, Im YK, Kleinman C, Muller WJ and Ursini-Siegel J (2018). Integration of distinct ShcA signaling complexes promotes breast tumor growth and tyrosine kinase inhibitor resistance. Mol Cancer Res 16(5), 894-908
